Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report

Giacomo Bertelli; Rosalinda Trovato; Stefano Ugel; Emilio Bria; Michele Milella; Vincenzo Bronte; Sara Pilotto

doi:10.1016/j.cllc.2019.04.013

Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report

Giacomo Bertelli, Rosalinda Trovato, Stefano Ugel, Emilio Bria, Michele Milella, Vincenzo Bronte, Sara Pilotto

IRCCS Fondazione Policlinico Universitario A. Gemelli

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	e514-e516
Journal	Clinical Lung Cancer
Volume	20
Issue number	4
DOIs	https://doi.org/10.1016/j.cllc.2019.04.013
Publication status	Published - Jul 2019

Cite this

Bertelli, G., Trovato, R., Ugel, S., Bria, E., Milella, M., Bronte, V., & Pilotto, S. (2019). Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report. Clinical Lung Cancer, 20(4), e514-e516. https://doi.org/10.1016/j.cllc.2019.04.013

Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment : A Case Report. / Bertelli, Giacomo; Trovato, Rosalinda; Ugel, Stefano; Bria, Emilio; Milella, Michele; Bronte, Vincenzo; Pilotto, Sara.

In: Clinical Lung Cancer, Vol. 20, No. 4, 07.2019, p. e514-e516.

Research output: Contribution to journal › Article

@article{3963185dc8ad4afda1430832b19802ba,

title = "Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report",

author = "Giacomo Bertelli and Rosalinda Trovato and Stefano Ugel and Emilio Bria and Michele Milella and Vincenzo Bronte and Sara Pilotto",

year = "2019",

month = jul

doi = "10.1016/j.cllc.2019.04.013",

language = "English",

volume = "20",

pages = "e514--e516",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment

T2 - A Case Report

AU - Bertelli, Giacomo

AU - Trovato, Rosalinda

AU - Ugel, Stefano

AU - Bria, Emilio

AU - Milella, Michele

AU - Bronte, Vincenzo

AU - Pilotto, Sara

PY - 2019/7

Y1 - 2019/7

U2 - 10.1016/j.cllc.2019.04.013

DO - 10.1016/j.cllc.2019.04.013

M3 - Article

C2 - 31122866

VL - 20

SP - e514-e516

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - 4

ER -

Access to Document

10.1016/j.cllc.2019.04.013

Projects

FONDAZIONE GEMELLI - Ricerca Clinica in Medicina Personalizzata delle malattie croniche complesse

Project: Other project

Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report

Cite this

Access to Document

Related content

Projects

FONDAZIONE GEMELLI - Ricerca Clinica in Medicina Personalizzata delle malattie croniche complesse